Drug Pipeline

Crizanlizumab Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
2
Recruiting
2
Phase 3
1
Top Sponsors
Active Studies by Phase
Phase 4
1
Phase 3
2
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT04657822 Rollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior… Sickle Cell Disease Recruiting
Phase 3
NCT06439082 A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With… Sickle Cell Disease Recruiting
NCT03814746 Study of Two Doses of Crizanlizumab Versus Placebo in Adolescent and Adult Sickle Cell… Sickle Cell Disease (SCD) Active, Not Recruiting
Sponsors Running Crizanlizumab Trials
Novartis Pharmaceuticals (3)
Disease Areas
Sickle Cell Disease (3)
Get alerts when Crizanlizumab trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free